nodes	percent_of_prediction	percent_of_DWPC	metapath
Sotalol—ADRB1—obesity	0.256	0.543	CbGaD
Sotalol—ADRB2—obesity	0.215	0.457	CbGaD
Sotalol—ADRB2—Phenylpropanolamine—obesity	0.171	0.504	CbGbCtD
Sotalol—ADRB1—Phenylpropanolamine—obesity	0.169	0.496	CbGbCtD
Sotalol—Isoprenaline—PIK3R1—obesity	0.000898	0.177	CrCbGaD
Sotalol—Ibuprofen—FABP2—obesity	0.000814	0.16	CrCbGaD
Sotalol—Orciprenaline—ADRB2—obesity	0.00047	0.0924	CrCbGaD
Sotalol—Practolol—ADRB1—obesity	0.000423	0.0833	CrCbGaD
Sotalol—Isoprenaline—ADRB3—obesity	0.000325	0.0638	CrCbGaD
Sotalol—Fatigue—Cimetidine—obesity	0.000317	0.00253	CcSEcCtD
Sotalol—Photosensitivity reaction—Sibutramine—obesity	0.000315	0.00251	CcSEcCtD
Sotalol—Atrioventricular block—Topiramate—obesity	0.000315	0.00251	CcSEcCtD
Sotalol—Cramp muscle—Bupropion—obesity	0.000313	0.0025	CcSEcCtD
Sotalol—Neuropathy peripheral—Orlistat—obesity	0.000312	0.00249	CcSEcCtD
Sotalol—Hyperglycaemia—Sibutramine—obesity	0.000311	0.00248	CcSEcCtD
Sotalol—Coordination abnormal—Topiramate—obesity	0.000311	0.00248	CcSEcCtD
Sotalol—Depression—Sibutramine—obesity	0.000307	0.00245	CcSEcCtD
Sotalol—Dizziness—Phenylpropanolamine—obesity	0.000307	0.00245	CcSEcCtD
Sotalol—Esmolol—ADRB1—obesity	0.000304	0.0598	CrCbGaD
Sotalol—Diarrhoea—Phentermine—obesity	0.000304	0.00242	CcSEcCtD
Sotalol—Acute coronary syndrome—Sibutramine—obesity	0.000303	0.00242	CcSEcCtD
Sotalol—Abdominal distension—Bupropion—obesity	0.000303	0.00242	CcSEcCtD
Sotalol—Neuropathy peripheral—Sibutramine—obesity	0.000302	0.00241	CcSEcCtD
Sotalol—Myocardial infarction—Sibutramine—obesity	0.000302	0.00241	CcSEcCtD
Sotalol—Influenza—Bupropion—obesity	0.000301	0.0024	CcSEcCtD
Sotalol—Asthma—Bupropion—obesity	0.000301	0.0024	CcSEcCtD
Sotalol—Bronchospasm—Bupropion—obesity	0.000296	0.00236	CcSEcCtD
Sotalol—Vomiting—Phenylpropanolamine—obesity	0.000295	0.00235	CcSEcCtD
Sotalol—Dizziness—Phentermine—obesity	0.000293	0.00234	CcSEcCtD
Sotalol—Rash—Phenylpropanolamine—obesity	0.000292	0.00233	CcSEcCtD
Sotalol—Dermatitis—Phenylpropanolamine—obesity	0.000292	0.00233	CcSEcCtD
Sotalol—Body temperature increased—Cimetidine—obesity	0.00029	0.00232	CcSEcCtD
Sotalol—Haemoglobin—Orlistat—obesity	0.000287	0.00229	CcSEcCtD
Sotalol—Photophobia—Topiramate—obesity	0.000287	0.00229	CcSEcCtD
Sotalol—Haemorrhage—Orlistat—obesity	0.000285	0.00228	CcSEcCtD
Sotalol—Vomiting—Phentermine—obesity	0.000282	0.00225	CcSEcCtD
Sotalol—Bradycardia—Sibutramine—obesity	0.000281	0.00224	CcSEcCtD
Sotalol—Rash—Phentermine—obesity	0.00028	0.00223	CcSEcCtD
Sotalol—Upper respiratory tract infection—Bupropion—obesity	0.00028	0.00223	CcSEcCtD
Sotalol—Dermatitis—Phentermine—obesity	0.00028	0.00223	CcSEcCtD
Sotalol—Headache—Phentermine—obesity	0.000278	0.00222	CcSEcCtD
Sotalol—Haemoglobin—Sibutramine—obesity	0.000278	0.00221	CcSEcCtD
Sotalol—Haemorrhage—Sibutramine—obesity	0.000276	0.0022	CcSEcCtD
Sotalol—Nausea—Phenylpropanolamine—obesity	0.000275	0.0022	CcSEcCtD
Sotalol—Photosensitivity reaction—Bupropion—obesity	0.000275	0.00219	CcSEcCtD
Sotalol—Hyperglycaemia—Bupropion—obesity	0.000271	0.00216	CcSEcCtD
Sotalol—Visual impairment—Sibutramine—obesity	0.000266	0.00212	CcSEcCtD
Sotalol—Atenolol—ADRB1—obesity	0.000265	0.0522	CrCbGaD
Sotalol—Acute coronary syndrome—Bupropion—obesity	0.000264	0.00211	CcSEcCtD
Sotalol—Diarrhoea—Diethylpropion—obesity	0.000264	0.00211	CcSEcCtD
Sotalol—Nausea—Phentermine—obesity	0.000264	0.0021	CcSEcCtD
Sotalol—Asthenia—Cimetidine—obesity	0.000264	0.0021	CcSEcCtD
Sotalol—Myocardial infarction—Bupropion—obesity	0.000263	0.0021	CcSEcCtD
Sotalol—Neuropathy peripheral—Bupropion—obesity	0.000263	0.0021	CcSEcCtD
Sotalol—Sleep disorder—Topiramate—obesity	0.000256	0.00204	CcSEcCtD
Sotalol—Esmolol—ADRB2—obesity	0.000256	0.0503	CrCbGaD
Sotalol—Dizziness—Diethylpropion—obesity	0.000255	0.00204	CcSEcCtD
Sotalol—Alopecia—Orlistat—obesity	0.000252	0.00201	CcSEcCtD
Sotalol—Diarrhoea—Cimetidine—obesity	0.000251	0.002	CcSEcCtD
Sotalol—Angiopathy—Sibutramine—obesity	0.000251	0.002	CcSEcCtD
Sotalol—Disorientation—Topiramate—obesity	0.000248	0.00198	CcSEcCtD
Sotalol—Vascular purpura—Topiramate—obesity	0.000248	0.00198	CcSEcCtD
Sotalol—Arrhythmia—Sibutramine—obesity	0.000247	0.00197	CcSEcCtD
Sotalol—Vomiting—Diethylpropion—obesity	0.000245	0.00196	CcSEcCtD
Sotalol—Flatulence—Orlistat—obesity	0.000245	0.00195	CcSEcCtD
Sotalol—Alopecia—Sibutramine—obesity	0.000244	0.00195	CcSEcCtD
Sotalol—Rash—Diethylpropion—obesity	0.000243	0.00194	CcSEcCtD
Sotalol—Dysgeusia—Orlistat—obesity	0.000243	0.00194	CcSEcCtD
Sotalol—Dermatitis—Diethylpropion—obesity	0.000243	0.00194	CcSEcCtD
Sotalol—Dizziness—Cimetidine—obesity	0.000243	0.00194	CcSEcCtD
Sotalol—Haemoglobin—Bupropion—obesity	0.000242	0.00193	CcSEcCtD
Sotalol—Headache—Diethylpropion—obesity	0.000242	0.00193	CcSEcCtD
Sotalol—Haemorrhage—Bupropion—obesity	0.000241	0.00192	CcSEcCtD
Sotalol—Back pain—Orlistat—obesity	0.00024	0.00192	CcSEcCtD
Sotalol—Muscle spasms—Orlistat—obesity	0.000239	0.00191	CcSEcCtD
Sotalol—Flatulence—Sibutramine—obesity	0.000237	0.00189	CcSEcCtD
Sotalol—Amnesia—Topiramate—obesity	0.000236	0.00188	CcSEcCtD
Sotalol—Dysgeusia—Sibutramine—obesity	0.000236	0.00188	CcSEcCtD
Sotalol—Vision blurred—Orlistat—obesity	0.000234	0.00187	CcSEcCtD
Sotalol—Visual disturbance—Topiramate—obesity	0.000234	0.00187	CcSEcCtD
Sotalol—Vomiting—Cimetidine—obesity	0.000234	0.00186	CcSEcCtD
Sotalol—Back pain—Sibutramine—obesity	0.000233	0.00185	CcSEcCtD
Sotalol—Visual impairment—Bupropion—obesity	0.000232	0.00185	CcSEcCtD
Sotalol—Rash—Cimetidine—obesity	0.000232	0.00185	CcSEcCtD
Sotalol—Dermatitis—Cimetidine—obesity	0.000231	0.00185	CcSEcCtD
Sotalol—Muscle spasms—Sibutramine—obesity	0.000231	0.00184	CcSEcCtD
Sotalol—Headache—Cimetidine—obesity	0.00023	0.00184	CcSEcCtD
Sotalol—Purpura—Topiramate—obesity	0.00023	0.00184	CcSEcCtD
Sotalol—Nausea—Diethylpropion—obesity	0.000229	0.00183	CcSEcCtD
Sotalol—Ibuprofen—BCL2—obesity	0.000228	0.0449	CrCbGaD
Sotalol—Vision blurred—Sibutramine—obesity	0.000227	0.00181	CcSEcCtD
Sotalol—Lethargy—Topiramate—obesity	0.000226	0.0018	CcSEcCtD
Sotalol—Vertigo—Orlistat—obesity	0.000223	0.00178	CcSEcCtD
Sotalol—Atenolol—ADRB2—obesity	0.000223	0.0439	CrCbGaD
Sotalol—Pain in extremity—Topiramate—obesity	0.000222	0.00177	CcSEcCtD
Sotalol—Palpitations—Orlistat—obesity	0.00022	0.00175	CcSEcCtD
Sotalol—Angiopathy—Bupropion—obesity	0.000219	0.00174	CcSEcCtD
Sotalol—Affect lability—Topiramate—obesity	0.000218	0.00174	CcSEcCtD
Sotalol—Nausea—Cimetidine—obesity	0.000218	0.00174	CcSEcCtD
Sotalol—Cough—Orlistat—obesity	0.000217	0.00173	CcSEcCtD
Sotalol—Vertigo—Sibutramine—obesity	0.000216	0.00172	CcSEcCtD
Sotalol—Syncope—Sibutramine—obesity	0.000216	0.00172	CcSEcCtD
Sotalol—Leukopenia—Sibutramine—obesity	0.000215	0.00172	CcSEcCtD
Sotalol—Arrhythmia—Bupropion—obesity	0.000215	0.00172	CcSEcCtD
Sotalol—Alopecia—Bupropion—obesity	0.000213	0.0017	CcSEcCtD
Sotalol—Palpitations—Sibutramine—obesity	0.000213	0.00169	CcSEcCtD
Sotalol—Myalgia—Orlistat—obesity	0.000212	0.00169	CcSEcCtD
Sotalol—Chest pain—Orlistat—obesity	0.000212	0.00169	CcSEcCtD
Sotalol—Loss of consciousness—Sibutramine—obesity	0.000211	0.00169	CcSEcCtD
Sotalol—Anxiety—Orlistat—obesity	0.000211	0.00168	CcSEcCtD
Sotalol—Mood swings—Topiramate—obesity	0.00021	0.00168	CcSEcCtD
Sotalol—Cough—Sibutramine—obesity	0.00021	0.00167	CcSEcCtD
Sotalol—Hypertension—Sibutramine—obesity	0.000208	0.00166	CcSEcCtD
Sotalol—Metoprolol—ADRB1—obesity	0.000207	0.0407	CrCbGaD
Sotalol—Flatulence—Bupropion—obesity	0.000207	0.00165	CcSEcCtD
Sotalol—Dysgeusia—Bupropion—obesity	0.000205	0.00164	CcSEcCtD
Sotalol—Chest pain—Sibutramine—obesity	0.000205	0.00163	CcSEcCtD
Sotalol—Myalgia—Sibutramine—obesity	0.000205	0.00163	CcSEcCtD
Sotalol—Anxiety—Sibutramine—obesity	0.000204	0.00163	CcSEcCtD
Sotalol—Oedema—Orlistat—obesity	0.000203	0.00162	CcSEcCtD
Sotalol—Back pain—Bupropion—obesity	0.000203	0.00162	CcSEcCtD
Sotalol—Muscle spasms—Bupropion—obesity	0.000202	0.00161	CcSEcCtD
Sotalol—Infection—Orlistat—obesity	0.000201	0.00161	CcSEcCtD
Sotalol—Vision blurred—Bupropion—obesity	0.000198	0.00158	CcSEcCtD
Sotalol—Oedema—Sibutramine—obesity	0.000196	0.00157	CcSEcCtD
Sotalol—Hyperhidrosis—Orlistat—obesity	0.000196	0.00156	CcSEcCtD
Sotalol—Infection—Sibutramine—obesity	0.000195	0.00155	CcSEcCtD
Sotalol—Shock—Sibutramine—obesity	0.000193	0.00154	CcSEcCtD
Sotalol—Abdominal distension—Topiramate—obesity	0.000193	0.00154	CcSEcCtD
Sotalol—Thrombocytopenia—Sibutramine—obesity	0.000192	0.00153	CcSEcCtD
Sotalol—Asthma—Topiramate—obesity	0.000192	0.00153	CcSEcCtD
Sotalol—Eosinophilia—Topiramate—obesity	0.00019	0.00151	CcSEcCtD
Sotalol—Hyperhidrosis—Sibutramine—obesity	0.00019	0.00151	CcSEcCtD
Sotalol—Vertigo—Bupropion—obesity	0.000188	0.0015	CcSEcCtD
Sotalol—Syncope—Bupropion—obesity	0.000188	0.0015	CcSEcCtD
Sotalol—Leukopenia—Bupropion—obesity	0.000188	0.0015	CcSEcCtD
Sotalol—Angina pectoris—Topiramate—obesity	0.000187	0.00149	CcSEcCtD
Sotalol—Palpitations—Bupropion—obesity	0.000185	0.00148	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Orlistat—obesity	0.000185	0.00147	CcSEcCtD
Sotalol—Loss of consciousness—Bupropion—obesity	0.000184	0.00147	CcSEcCtD
Sotalol—Insomnia—Orlistat—obesity	0.000183	0.00146	CcSEcCtD
Sotalol—Hypotension—Sibutramine—obesity	0.000183	0.00146	CcSEcCtD
Sotalol—Cough—Bupropion—obesity	0.000183	0.00146	CcSEcCtD
Sotalol—Paraesthesia—Orlistat—obesity	0.000182	0.00145	CcSEcCtD
Sotalol—Hypertension—Bupropion—obesity	0.000181	0.00144	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Sibutramine—obesity	0.000179	0.00143	CcSEcCtD
Sotalol—Dyspepsia—Orlistat—obesity	0.000179	0.00142	CcSEcCtD
Sotalol—Myalgia—Bupropion—obesity	0.000178	0.00142	CcSEcCtD
Sotalol—Chest pain—Bupropion—obesity	0.000178	0.00142	CcSEcCtD
Sotalol—Upper respiratory tract infection—Topiramate—obesity	0.000178	0.00142	CcSEcCtD
Sotalol—Anxiety—Bupropion—obesity	0.000178	0.00142	CcSEcCtD
Sotalol—Insomnia—Sibutramine—obesity	0.000178	0.00142	CcSEcCtD
Sotalol—Decreased appetite—Orlistat—obesity	0.000176	0.00141	CcSEcCtD
Sotalol—Paraesthesia—Sibutramine—obesity	0.000176	0.00141	CcSEcCtD
Sotalol—Dyspnoea—Sibutramine—obesity	0.000175	0.0014	CcSEcCtD
Sotalol—Photosensitivity reaction—Topiramate—obesity	0.000175	0.0014	CcSEcCtD
Sotalol—Fatigue—Orlistat—obesity	0.000175	0.00139	CcSEcCtD
Sotalol—Somnolence—Sibutramine—obesity	0.000174	0.00139	CcSEcCtD
Sotalol—Metoprolol—ADRB2—obesity	0.000174	0.0342	CrCbGaD
Sotalol—Pain—Orlistat—obesity	0.000173	0.00138	CcSEcCtD
Sotalol—Hyperglycaemia—Topiramate—obesity	0.000173	0.00138	CcSEcCtD
Sotalol—Dyspepsia—Sibutramine—obesity	0.000173	0.00138	CcSEcCtD
Sotalol—Oedema—Bupropion—obesity	0.000171	0.00136	CcSEcCtD
Sotalol—Decreased appetite—Sibutramine—obesity	0.000171	0.00136	CcSEcCtD
Sotalol—Depression—Topiramate—obesity	0.00017	0.00136	CcSEcCtD
Sotalol—Infection—Bupropion—obesity	0.00017	0.00136	CcSEcCtD
Sotalol—Shock—Bupropion—obesity	0.000168	0.00134	CcSEcCtD
Sotalol—Pain—Sibutramine—obesity	0.000168	0.00134	CcSEcCtD
Sotalol—Neuropathy peripheral—Topiramate—obesity	0.000168	0.00134	CcSEcCtD
Sotalol—Thrombocytopenia—Bupropion—obesity	0.000168	0.00134	CcSEcCtD
Sotalol—Gastrointestinal pain—Orlistat—obesity	0.000166	0.00132	CcSEcCtD
Sotalol—Hyperhidrosis—Bupropion—obesity	0.000165	0.00132	CcSEcCtD
Sotalol—Gastrointestinal pain—Sibutramine—obesity	0.00016	0.00128	CcSEcCtD
Sotalol—Abdominal pain—Orlistat—obesity	0.00016	0.00128	CcSEcCtD
Sotalol—Body temperature increased—Orlistat—obesity	0.00016	0.00128	CcSEcCtD
Sotalol—Hypotension—Bupropion—obesity	0.00016	0.00127	CcSEcCtD
Sotalol—Agranulocytosis—Topiramate—obesity	0.00016	0.00127	CcSEcCtD
Sotalol—Bradycardia—Topiramate—obesity	0.000156	0.00125	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Bupropion—obesity	0.000156	0.00124	CcSEcCtD
Sotalol—Body temperature increased—Sibutramine—obesity	0.000155	0.00124	CcSEcCtD
Sotalol—Abdominal pain—Sibutramine—obesity	0.000155	0.00124	CcSEcCtD
Sotalol—Insomnia—Bupropion—obesity	0.000155	0.00123	CcSEcCtD
Sotalol—Haemoglobin—Topiramate—obesity	0.000154	0.00123	CcSEcCtD
Sotalol—Paraesthesia—Bupropion—obesity	0.000154	0.00123	CcSEcCtD
Sotalol—Haemorrhage—Topiramate—obesity	0.000153	0.00122	CcSEcCtD
Sotalol—Dyspnoea—Bupropion—obesity	0.000153	0.00122	CcSEcCtD
Sotalol—Somnolence—Bupropion—obesity	0.000152	0.00121	CcSEcCtD
Sotalol—Dyspepsia—Bupropion—obesity	0.000151	0.0012	CcSEcCtD
Sotalol—Decreased appetite—Bupropion—obesity	0.000149	0.00119	CcSEcCtD
Sotalol—Visual impairment—Topiramate—obesity	0.000148	0.00118	CcSEcCtD
Sotalol—Fatigue—Bupropion—obesity	0.000148	0.00118	CcSEcCtD
Sotalol—Isoprenaline—ADRB1—obesity	0.000147	0.0289	CrCbGaD
Sotalol—Pain—Bupropion—obesity	0.000146	0.00117	CcSEcCtD
Sotalol—Asthenia—Orlistat—obesity	0.000146	0.00116	CcSEcCtD
Sotalol—Pruritus—Orlistat—obesity	0.000143	0.00114	CcSEcCtD
Sotalol—Asthenia—Sibutramine—obesity	0.000141	0.00112	CcSEcCtD
Sotalol—Gastrointestinal pain—Bupropion—obesity	0.00014	0.00112	CcSEcCtD
Sotalol—Angiopathy—Topiramate—obesity	0.000139	0.00111	CcSEcCtD
Sotalol—Pruritus—Sibutramine—obesity	0.000139	0.00111	CcSEcCtD
Sotalol—Diarrhoea—Orlistat—obesity	0.000139	0.00111	CcSEcCtD
Sotalol—Alopecia—Topiramate—obesity	0.000136	0.00108	CcSEcCtD
Sotalol—Abdominal pain—Bupropion—obesity	0.000135	0.00108	CcSEcCtD
Sotalol—Body temperature increased—Bupropion—obesity	0.000135	0.00108	CcSEcCtD
Sotalol—Diarrhoea—Sibutramine—obesity	0.000134	0.00107	CcSEcCtD
Sotalol—Dizziness—Orlistat—obesity	0.000134	0.00107	CcSEcCtD
Sotalol—Flatulence—Topiramate—obesity	0.000132	0.00105	CcSEcCtD
Sotalol—Dysgeusia—Topiramate—obesity	0.000131	0.00104	CcSEcCtD
Sotalol—Dizziness—Sibutramine—obesity	0.00013	0.00103	CcSEcCtD
Sotalol—Back pain—Topiramate—obesity	0.000129	0.00103	CcSEcCtD
Sotalol—Vomiting—Orlistat—obesity	0.000129	0.00103	CcSEcCtD
Sotalol—Muscle spasms—Topiramate—obesity	0.000128	0.00102	CcSEcCtD
Sotalol—Rash—Orlistat—obesity	0.000128	0.00102	CcSEcCtD
Sotalol—Dermatitis—Orlistat—obesity	0.000128	0.00102	CcSEcCtD
Sotalol—Headache—Orlistat—obesity	0.000127	0.00101	CcSEcCtD
Sotalol—Ibuprofen—PPARG—obesity	0.000126	0.0249	CrCbGaD
Sotalol—Vision blurred—Topiramate—obesity	0.000126	0.001	CcSEcCtD
Sotalol—Vomiting—Sibutramine—obesity	0.000125	0.000995	CcSEcCtD
Sotalol—Rash—Sibutramine—obesity	0.000124	0.000987	CcSEcCtD
Sotalol—Dermatitis—Sibutramine—obesity	0.000124	0.000986	CcSEcCtD
Sotalol—Isoprenaline—ADRB2—obesity	0.000123	0.0243	CrCbGaD
Sotalol—Headache—Sibutramine—obesity	0.000123	0.00098	CcSEcCtD
Sotalol—Asthenia—Bupropion—obesity	0.000123	0.000979	CcSEcCtD
Sotalol—Pruritus—Bupropion—obesity	0.000121	0.000965	CcSEcCtD
Sotalol—Nausea—Orlistat—obesity	0.00012	0.000961	CcSEcCtD
Sotalol—Vertigo—Topiramate—obesity	0.00012	0.000957	CcSEcCtD
Sotalol—Syncope—Topiramate—obesity	0.00012	0.000955	CcSEcCtD
Sotalol—Leukopenia—Topiramate—obesity	0.00012	0.000953	CcSEcCtD
Sotalol—Palpitations—Topiramate—obesity	0.000118	0.000941	CcSEcCtD
Sotalol—Loss of consciousness—Topiramate—obesity	0.000117	0.000936	CcSEcCtD
Sotalol—Diarrhoea—Bupropion—obesity	0.000117	0.000934	CcSEcCtD
Sotalol—Nausea—Sibutramine—obesity	0.000117	0.00093	CcSEcCtD
Sotalol—Cough—Topiramate—obesity	0.000117	0.000929	CcSEcCtD
Sotalol—Hypertension—Topiramate—obesity	0.000115	0.00092	CcSEcCtD
Sotalol—Myalgia—Topiramate—obesity	0.000114	0.000907	CcSEcCtD
Sotalol—Chest pain—Topiramate—obesity	0.000114	0.000907	CcSEcCtD
Sotalol—Anxiety—Topiramate—obesity	0.000113	0.000904	CcSEcCtD
Sotalol—Dizziness—Bupropion—obesity	0.000113	0.000902	CcSEcCtD
Sotalol—Oedema—Topiramate—obesity	0.000109	0.000869	CcSEcCtD
Sotalol—Vomiting—Bupropion—obesity	0.000109	0.000868	CcSEcCtD
Sotalol—Infection—Topiramate—obesity	0.000108	0.000864	CcSEcCtD
Sotalol—Rash—Bupropion—obesity	0.000108	0.00086	CcSEcCtD
Sotalol—Dermatitis—Bupropion—obesity	0.000108	0.00086	CcSEcCtD
Sotalol—Shock—Topiramate—obesity	0.000107	0.000855	CcSEcCtD
Sotalol—Headache—Bupropion—obesity	0.000107	0.000855	CcSEcCtD
Sotalol—Thrombocytopenia—Topiramate—obesity	0.000107	0.000851	CcSEcCtD
Sotalol—Hyperhidrosis—Topiramate—obesity	0.000105	0.00084	CcSEcCtD
Sotalol—Hypotension—Topiramate—obesity	0.000102	0.000812	CcSEcCtD
Sotalol—Nausea—Bupropion—obesity	0.000102	0.00081	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Topiramate—obesity	9.93e-05	0.000792	CcSEcCtD
Sotalol—Insomnia—Topiramate—obesity	9.86e-05	0.000786	CcSEcCtD
Sotalol—Paraesthesia—Topiramate—obesity	9.79e-05	0.000781	CcSEcCtD
Sotalol—Dyspnoea—Topiramate—obesity	9.72e-05	0.000775	CcSEcCtD
Sotalol—Somnolence—Topiramate—obesity	9.69e-05	0.000773	CcSEcCtD
Sotalol—Dyspepsia—Topiramate—obesity	9.6e-05	0.000765	CcSEcCtD
Sotalol—Decreased appetite—Topiramate—obesity	9.48e-05	0.000756	CcSEcCtD
Sotalol—Fatigue—Topiramate—obesity	9.4e-05	0.000749	CcSEcCtD
Sotalol—Pain—Topiramate—obesity	9.32e-05	0.000743	CcSEcCtD
Sotalol—Gastrointestinal pain—Topiramate—obesity	8.91e-05	0.000711	CcSEcCtD
Sotalol—Abdominal pain—Topiramate—obesity	8.62e-05	0.000687	CcSEcCtD
Sotalol—Body temperature increased—Topiramate—obesity	8.62e-05	0.000687	CcSEcCtD
Sotalol—Asthenia—Topiramate—obesity	7.82e-05	0.000624	CcSEcCtD
Sotalol—Pruritus—Topiramate—obesity	7.71e-05	0.000615	CcSEcCtD
Sotalol—Diarrhoea—Topiramate—obesity	7.46e-05	0.000595	CcSEcCtD
Sotalol—Dizziness—Topiramate—obesity	7.21e-05	0.000575	CcSEcCtD
Sotalol—Vomiting—Topiramate—obesity	6.93e-05	0.000553	CcSEcCtD
Sotalol—Rash—Topiramate—obesity	6.87e-05	0.000548	CcSEcCtD
Sotalol—Dermatitis—Topiramate—obesity	6.87e-05	0.000548	CcSEcCtD
Sotalol—Headache—Topiramate—obesity	6.83e-05	0.000545	CcSEcCtD
Sotalol—Nausea—Topiramate—obesity	6.48e-05	0.000516	CcSEcCtD
Sotalol—Ibuprofen—PTGS2—obesity	5.34e-05	0.0105	CrCbGaD
Sotalol—Ibuprofen—ALB—obesity	4.76e-05	0.00936	CrCbGaD
Sotalol—ADRB2—Signaling by GPCR—DRD4—obesity	2.08e-05	0.000354	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CCL2—obesity	2.07e-05	0.000351	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CNR1—obesity	2.03e-05	0.000345	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CNR1—obesity	1.99e-05	0.000338	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—DRD2—obesity	1.99e-05	0.000337	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—GCG—obesity	1.97e-05	0.000333	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—ADRB2—obesity	1.96e-05	0.000332	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ADRB3—obesity	1.95e-05	0.00033	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—DRD2—obesity	1.94e-05	0.000329	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—GCG—obesity	1.92e-05	0.000326	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ADRB3—obesity	1.9e-05	0.000323	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GAL—obesity	1.9e-05	0.000322	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—C5AR1—obesity	1.88e-05	0.000319	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—GNB3—obesity	1.87e-05	0.000316	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GAL—obesity	1.86e-05	0.000315	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—C5AR1—obesity	1.84e-05	0.000312	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—GNB3—obesity	1.82e-05	0.000309	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—GNAS—obesity	1.82e-05	0.000308	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—ADRB2—obesity	1.78e-05	0.000302	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—GNAS—obesity	1.78e-05	0.000301	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CCL5—obesity	1.74e-05	0.000295	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PRKG1—obesity	1.72e-05	0.000291	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCK—obesity	1.72e-05	0.000291	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CCL5—obesity	1.7e-05	0.000288	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—GNB3—obesity	1.69e-05	0.000287	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PRKG1—obesity	1.68e-05	0.000285	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCK—obesity	1.68e-05	0.000285	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—RBP4—obesity	1.67e-05	0.000284	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GLP1R—obesity	1.67e-05	0.000284	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—GNB3—obesity	1.66e-05	0.000281	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—GNAS—obesity	1.65e-05	0.00028	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCKAR—obesity	1.65e-05	0.000279	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HRH3—obesity	1.65e-05	0.000279	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—RBP4—obesity	1.64e-05	0.000278	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GLP1R—obesity	1.64e-05	0.000278	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—GNAS—obesity	1.61e-05	0.000274	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCKAR—obesity	1.61e-05	0.000273	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HRH3—obesity	1.61e-05	0.000273	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PRKAR2B—obesity	1.59e-05	0.000269	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CCL5—obesity	1.58e-05	0.000267	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PRKCD—obesity	1.56e-05	0.000265	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PRKAR2B—obesity	1.55e-05	0.000263	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CCL5—obesity	1.54e-05	0.000262	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NCF2—obesity	1.53e-05	0.00026	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—HTR2A—obesity	1.53e-05	0.00026	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PRKCD—obesity	1.53e-05	0.00026	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—C3—obesity	1.53e-05	0.000259	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NCF2—obesity	1.5e-05	0.000254	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—HTR2A—obesity	1.5e-05	0.000254	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—C3—obesity	1.5e-05	0.000254	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NPY—obesity	1.49e-05	0.000253	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—APOC3—obesity	1.48e-05	0.000252	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IAPP—obesity	1.48e-05	0.000252	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NPY—obesity	1.46e-05	0.000248	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—AGT—obesity	1.45e-05	0.000246	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—APOC3—obesity	1.45e-05	0.000246	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IAPP—obesity	1.45e-05	0.000246	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HTR1B—obesity	1.44e-05	0.000244	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CRH—obesity	1.44e-05	0.000244	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SDC1—obesity	1.42e-05	0.000242	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—AGT—obesity	1.42e-05	0.000241	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PRKCD—obesity	1.42e-05	0.000241	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HTR1B—obesity	1.41e-05	0.000239	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CRH—obesity	1.41e-05	0.000239	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AKR1C3—obesity	1.4e-05	0.000238	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SDC1—obesity	1.39e-05	0.000236	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—HTR2A—obesity	1.39e-05	0.000236	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PRKCD—obesity	1.39e-05	0.000236	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—C3—obesity	1.39e-05	0.000235	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AKR1C3—obesity	1.37e-05	0.000232	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NPS—obesity	1.37e-05	0.000232	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—HTR2A—obesity	1.36e-05	0.000231	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—C3—obesity	1.36e-05	0.00023	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—F2—obesity	1.34e-05	0.000228	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PRKCB—obesity	1.34e-05	0.000228	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HTR2C—obesity	1.34e-05	0.000227	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—DRD1—obesity	1.34e-05	0.000227	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NPS—obesity	1.34e-05	0.000227	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—AGT—obesity	1.32e-05	0.000224	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PRKCB—obesity	1.31e-05	0.000223	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—F2—obesity	1.31e-05	0.000223	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HTR2C—obesity	1.31e-05	0.000222	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—DRD1—obesity	1.31e-05	0.000222	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NTRK2—obesity	1.3e-05	0.000221	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—AGT—obesity	1.29e-05	0.000219	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CG—obesity	1.28e-05	0.000218	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NTRK2—obesity	1.27e-05	0.000216	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PARP1—obesity	1.27e-05	0.000215	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GHRL—obesity	1.27e-05	0.000215	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ADRB1—obesity	1.27e-05	0.000215	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—DRD4—obesity	1.26e-05	0.000213	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CG—obesity	1.26e-05	0.000213	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GHRL—obesity	1.24e-05	0.000211	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PARP1—obesity	1.24e-05	0.000211	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—DRD4—obesity	1.23e-05	0.000209	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—POMC—obesity	1.22e-05	0.000207	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—F2—obesity	1.22e-05	0.000207	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PRKCB—obesity	1.22e-05	0.000207	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CNR1—obesity	1.2e-05	0.000204	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—POMC—obesity	1.2e-05	0.000203	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—F2—obesity	1.19e-05	0.000202	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PRKCB—obesity	1.19e-05	0.000202	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TCF7L2—obesity	1.18e-05	0.0002	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CNR1—obesity	1.18e-05	0.000199	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—AKT2—obesity	1.18e-05	0.000199	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—DRD2—obesity	1.17e-05	0.000199	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CG—obesity	1.17e-05	0.000198	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GCG—obesity	1.16e-05	0.000197	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PTPN1—obesity	1.16e-05	0.000197	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TCF7L2—obesity	1.16e-05	0.000196	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—AKT2—obesity	1.15e-05	0.000195	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—DRD2—obesity	1.15e-05	0.000195	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CG—obesity	1.14e-05	0.000194	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GCG—obesity	1.14e-05	0.000193	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PTPN1—obesity	1.14e-05	0.000193	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CD—obesity	1.13e-05	0.000192	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—POMC—obesity	1.11e-05	0.000188	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PRL—obesity	1.11e-05	0.000188	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CD—obesity	1.1e-05	0.000187	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—STK11—obesity	1.09e-05	0.000185	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CCL2—obesity	1.09e-05	0.000184	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—POMC—obesity	1.09e-05	0.000184	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PRL—obesity	1.08e-05	0.000184	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PLG—obesity	1.08e-05	0.000183	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—RHOA—obesity	1.08e-05	0.000183	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—STK11—obesity	1.07e-05	0.000181	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—AKT2—obesity	1.07e-05	0.000181	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3R1—obesity	1.07e-05	0.000181	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CCL2—obesity	1.06e-05	0.00018	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PLG—obesity	1.06e-05	0.000179	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—RHOA—obesity	1.05e-05	0.000179	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FOXO3—obesity	1.05e-05	0.000179	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ADRB2—obesity	1.05e-05	0.000178	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—AKT2—obesity	1.04e-05	0.000177	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3R1—obesity	1.04e-05	0.000177	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SOCS1—obesity	1.03e-05	0.000175	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FOXO3—obesity	1.03e-05	0.000175	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CD—obesity	1.03e-05	0.000174	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SOCS3—obesity	1.02e-05	0.000173	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SOCS1—obesity	1.01e-05	0.000172	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CD—obesity	1e-05	0.00017	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GNB3—obesity	1e-05	0.00017	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SOCS3—obesity	1e-05	0.00017	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—TYK2—obesity	9.87e-06	0.000167	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CB—obesity	9.84e-06	0.000167	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IGF2—obesity	9.83e-06	0.000167	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GNB3—obesity	9.79e-06	0.000166	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—RHOA—obesity	9.78e-06	0.000166	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GNAS—obesity	9.74e-06	0.000165	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3R1—obesity	9.68e-06	0.000164	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—TYK2—obesity	9.65e-06	0.000164	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CB—obesity	9.63e-06	0.000163	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IGF2—obesity	9.61e-06	0.000163	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—RHOA—obesity	9.57e-06	0.000162	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—APOB—obesity	9.54e-06	0.000162	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GNAS—obesity	9.53e-06	0.000162	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3R1—obesity	9.47e-06	0.000161	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—APOB—obesity	9.33e-06	0.000158	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCL5—obesity	9.32e-06	0.000158	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCL5—obesity	9.11e-06	0.000155	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—LPL—obesity	9.11e-06	0.000154	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FOXO1—obesity	9.04e-06	0.000153	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—RPS6KB1—obesity	9.03e-06	0.000153	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CB—obesity	8.94e-06	0.000152	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—LPL—obesity	8.91e-06	0.000151	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FOXO1—obesity	8.85e-06	0.00015	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—RPS6KB1—obesity	8.83e-06	0.00015	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CB—obesity	8.74e-06	0.000148	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PRKCD—obesity	8.39e-06	0.000142	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HTR2A—obesity	8.21e-06	0.000139	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PRKCD—obesity	8.21e-06	0.000139	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—C3—obesity	8.2e-06	0.000139	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HTR2A—obesity	8.03e-06	0.000136	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—C3—obesity	8.02e-06	0.000136	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IRS2—obesity	7.8e-06	0.000132	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AGT—obesity	7.79e-06	0.000132	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—LEP—obesity	7.64e-06	0.000129	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—APOE—obesity	7.64e-06	0.000129	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IRS2—obesity	7.63e-06	0.000129	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AGT—obesity	7.62e-06	0.000129	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CAV1—obesity	7.57e-06	0.000128	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—APOA1—obesity	7.55e-06	0.000128	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—LEP—obesity	7.47e-06	0.000127	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—APOE—obesity	7.47e-06	0.000127	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CAV1—obesity	7.4e-06	0.000126	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—APOA1—obesity	7.38e-06	0.000125	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ESR1—obesity	7.29e-06	0.000124	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—F2—obesity	7.2e-06	0.000122	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PRKCB—obesity	7.2e-06	0.000122	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ESR1—obesity	7.13e-06	0.000121	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—BAD—obesity	7.12e-06	0.000121	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PRKCB—obesity	7.04e-06	0.000119	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—F2—obesity	7.04e-06	0.000119	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—BAD—obesity	6.96e-06	0.000118	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CG—obesity	6.89e-06	0.000117	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IRS1—obesity	6.81e-06	0.000116	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CG—obesity	6.74e-06	0.000114	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IRS1—obesity	6.66e-06	0.000113	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—POMC—obesity	6.56e-06	0.000111	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—INS—obesity	6.52e-06	0.000111	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCL2—obesity	6.42e-06	0.000109	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—POMC—obesity	6.42e-06	0.000109	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—INS—obesity	6.38e-06	0.000108	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IGF1—obesity	6.31e-06	0.000107	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AKT2—obesity	6.31e-06	0.000107	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCL2—obesity	6.28e-06	0.000106	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IGF1—obesity	6.17e-06	0.000105	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AKT2—obesity	6.17e-06	0.000105	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CD—obesity	6.06e-06	0.000103	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CA—obesity	6e-06	0.000102	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SERPINE1—obesity	5.99e-06	0.000102	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CD—obesity	5.93e-06	0.000101	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CA—obesity	5.87e-06	9.95e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SERPINE1—obesity	5.86e-06	9.94e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TYK2—obesity	5.83e-06	9.88e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—RHOA—obesity	5.78e-06	9.8e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3R1—obesity	5.72e-06	9.7e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NOS3—obesity	5.72e-06	9.7e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TYK2—obesity	5.7e-06	9.67e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—RHOA—obesity	5.65e-06	9.59e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3R1—obesity	5.6e-06	9.49e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NOS3—obesity	5.6e-06	9.49e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CA—obesity	5.45e-06	9.24e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CA—obesity	5.33e-06	9.04e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MTOR—obesity	5.28e-06	8.96e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CB—obesity	5.28e-06	8.96e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MTOR—obesity	5.17e-06	8.76e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CB—obesity	5.17e-06	8.76e-05	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—AKT1—obesity	4.9e-06	8.31e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—IL6—obesity	4.83e-06	8.18e-05	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—AKT1—obesity	4.8e-06	8.13e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—IL6—obesity	4.72e-06	8e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MMP9—obesity	4.59e-06	7.78e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MMP9—obesity	4.49e-06	7.61e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MAPK8—obesity	4.46e-06	7.57e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—AKT1—obesity	4.45e-06	7.55e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MAPK8—obesity	4.37e-06	7.41e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—AKT1—obesity	4.35e-06	7.38e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—STAT3—obesity	4.08e-06	6.92e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—STAT3—obesity	3.99e-06	6.77e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MYC—obesity	3.79e-06	6.43e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TGFB1—obesity	3.78e-06	6.42e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MYC—obesity	3.71e-06	6.29e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TGFB1—obesity	3.7e-06	6.28e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CA—obesity	3.22e-06	5.46e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CA—obesity	3.15e-06	5.34e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IL6—obesity	2.85e-06	4.83e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IL6—obesity	2.79e-06	4.73e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AKT1—obesity	2.63e-06	4.46e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AKT1—obesity	2.57e-06	4.36e-05	CbGpPWpGaD
